Concepedia

Author

Robert Weiss

Maine Research AssociatesORCID

Also Known As

Edmund Claxton, J. Srebro, M. Imburgia, R J Weiss, R Weiss, R. J. Weiss, R. Weiss, ROBERT J. WEISS, Robert G. Weiss, Robert J Weiss

152

Publications

7.7K

Citations

41

H-Index

154

Concepts

All Affiliations

Maine Research AssociatesUniversity of MichiganRegeneron (United States)Amgen (United States)Tulane University
RW

About

Robert Weiss is an author at Maine Research Associates specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

38

3.2K

2

Public Health

8

8

670

3

Health Sciences

6

6

339

4

Education

3

3

142

5

Nursing

3

3

82

Robert Weiss

×

71

Publications

6.7K

Citations

37

H-Index

YearCitations

Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

William C. Cushman, Charles E. Ford, Jeffrey A. Cutler,

Journal of Clinical Hypertension

2002

981

Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

Evan A. Stein, Dan Gipe, Jean Bergeron,

The Lancet

2012

575

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson, Bettina S. Nedergaard, William J. Rogers,

JAMA

2014

492

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

M H Weinberger, Barbara Roniker, Scott Krause,

American Journal of Hypertension

2002

384

Intracoronary Fibrinolytic Therapy in Acute Myocardial Infarction

Fareed Khaja, Joseph A. Walton, James F. Brymer,

New England Journal of Medicine

1983

382

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

Michael A. Weber, Henry R. Black, George L. Bakris,

The Lancet

2009

329

Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial

Harold Bays, Daniel Gaudet, Robert Weiss,

The Journal of Clinical Endocrinology & Metabolism

2015

219

Efficacy and Safety of Fasudil in Patients With Stable Angina

Ralph Vicari, Bernard Chaitman, Deborah Keefe,

Journal of the American College of Cardiology

2005

200

Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)

Christie M. Ballantyne, Robert Weiss, Tiziano Moccetti,

The American Journal of Cardiology

2007

195

Comparison of psychologic outcome in adult survivors of childhood acute lymphoblastic leukemia versus sibling controls: a cooperative Children's Cancer Group and National Institutes of Health study.

Lonnie K. Zeltzer, E Chen, Robert Weiss,

Journal of Clinical Oncology

1997

150

Page 1